Australia-Europe Malaria Research Cooperation - OzEMalaR
Funder
National Health and Medical Research Council
Funding Amount
$859,731.00
Summary
EVIMalaR is a European Virtual Institute for Malaria Research that combines 42 of the European Union’s leading malaria research groups plus 4 Africans, 1 Indian institution, and 1 Australian. EVIMalaR faculty will combine expertise to produce a Network of Excellence that enhances and harmonises experimental approaches through shared technological platforms, exchange visits, shared PhD students, shared resources such as databases, reagent banks and protocols across pathology, infection, immunolog ....EVIMalaR is a European Virtual Institute for Malaria Research that combines 42 of the European Union’s leading malaria research groups plus 4 Africans, 1 Indian institution, and 1 Australian. EVIMalaR faculty will combine expertise to produce a Network of Excellence that enhances and harmonises experimental approaches through shared technological platforms, exchange visits, shared PhD students, shared resources such as databases, reagent banks and protocols across pathology, infection, immunology and biochemistry. Malaria is a global problem with no single solution. A large, but sometimes disjointed, research community is addressing the problem, but more collaboration is vital. OzEMalaR will link 34 Australian labs with 47 European, African and Indian malaria researchers. Funding will enable exchange of modern technologies by supporting early career researchers (PhD and postdocs) from Australia to work and be trained in top European labs. European trainees will work and be trained by Australian malariologists using reciprocal EU supportRead moreRead less
Transport Of Amino Acids And Polyamines In The Malaria Parasite
Funder
National Health and Medical Research Council
Funding Amount
$415,631.00
Summary
Malaria is one of the major infectious diseases challenging the world today. There is no effective vaccine, and the malaria parasite has developed resistance to most of the antimalarial drugs that we presently have available. This work focuses on the molecular mechanisms by which the malaria parasite takes up particular classes of nutrients from the surrounding environment. It paves the way for the exploitation of these mechanisms as new and much-needed antimalarial drug targets.
Ion Transport In The Malaria Parasite, Plasmodium Falciparum
Funder
National Health and Medical Research Council
Funding Amount
$225,721.00
Summary
Malaria is an infectious disease caused by single-cell protozoan parasites which, during the course of their complex lifecycle, invade the red blood cells of their human hosts. In recent years the emergence and spread of malaria parasites with high levels of antimalarial drug resistance has given rise to the very real possibility that within a few years, there will be large parts of the world in which malaria is an untreatable disease. There is therefore an urgent need for new antimalarial drugs ....Malaria is an infectious disease caused by single-cell protozoan parasites which, during the course of their complex lifecycle, invade the red blood cells of their human hosts. In recent years the emergence and spread of malaria parasites with high levels of antimalarial drug resistance has given rise to the very real possibility that within a few years, there will be large parts of the world in which malaria is an untreatable disease. There is therefore an urgent need for new antimalarial drugs. Despite the enormous clinical significance of the malaria parasite, the basic physiology of this organism is not understood. Pathways involved in ion balance, in the uptake of essential nutrients and in the release of potentially toxic waste products all play a crucial role in the survival of the parasite and are potential chemotherapeutic targets. However the properties of these pathways are, as yet, largely unknown. This work will provide fundamental (and pharmacological) information about these pathways. It will thereby open up exciting new possibilities with regard to the chemotherapy of malaria and will provide a rational basis for a strategy in which these pathways might be exploited as antimalarial drug targets.Read moreRead less